Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

PaperCitations, authors & open-access status

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 488 citations, 2019 year and green oa status.

488
Citations
2019
Year
green
OA Status

Related on ScholarIQ

Robert A. Burger
Author
Elizabeth M. Swisher
Author
Robert L. Coleman
Author
Carol Aghajanian
Author
Bradley J. Monk
Author
Journal of Clinical Oncology
Journal
470M+ articles · free account